MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jacadv.2025.102164

Медицинская библиотека · JACC. Advances · 2025

A Randomized Trial of a Resilience-Building Intervention in Adult Outpatients With Congenital Heart Disease: Feasibility and Efficacy.

Steiner Jill M, Marshall Arisa Rei, Brumback Lyndia, Zhang Yixuan Connie, Glenn Thomas M, Kovacs Adrienne H, Stout Karen K, Longenecker Chris T, Yi-Frazier Joyce P, Rosenberg Abby R

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Interventions are needed to address growing concerns regarding poor psychosocial and mental health in adult congenital heart disease (ACHD). Strengthening patients' resilience is one proposed pathway, given its ability to improve quality of life in other patient populations.

OBJECTIVES

The objective of this study was to evaluate feasibility and efficacy of a resilience-building intervention in ACHD.

METHODS

We conducted a clinical trial of outpatients with moderate or complex ACHD, randomized to receive a cognitive-behavioral intervention (Promoting Resilience in Stress Management [PRISM]) vs usual care. Participants completed surveys at randomization and 3 months. We evaluated feasibility using enrollment and retention rates. We evaluated PRISM's effect on the primary outcome (change in self-reported resilience) and exploratory outcomes using linear regression adjusted for baseline measurement.

RESULTS

We enrolled 78 patients from March 2023 to April 2024. Patients were randomized to treatment (PRISM; n = 40, age 36 ± 11 years; 50% female; 58% self-reported White race/ethnicity) vs control (n = 38, age 40 ± 12 years; 74% female; 79% White). Over three-quarters of participants randomized to treatment completed PRISM (80%) and follow-up measures. Of controls, 35/38 (92%) completed follow-up measures. Resilience scores at 3 months were higher in the treatment group (n = 30, 30.1 ± 8.1) compared to control (n = 35, 28.7 ± 5.8); this difference was not statistically significant. Mean quality of life at follow-up was significantly higher in the treatment group (79 ± 14 vs 73 ± 14; 95% CI: 0.8-12.7; P = 0.03). Program feedback was positive.

CONCLUSIONS

This study demonstrates intervention feasibility with modifications. Although we did not demonstrate efficacy, participants were engaged and provided valuable feedback, suggesting value in ACHD. (Assessing and Promoting Resilience in Patients With Adult Congenital Heart Disease [PRISMACHD]; NCT04738474).

Для цитирования: Steiner Jill M, Marshall Arisa Rei, Brumback Lyndia, Zhang Yixuan Connie, Glenn Thomas M, Kovacs Adrienne H, Stout Karen K, Longenecker Chris T, Yi-Frazier Joyce P, Rosenberg Abby R. A Randomized Trial of a Resilience-Building Intervention in Adult Outpatients With Congenital Heart Disease: Feasibility and Efficacy.. JACC. Advances. 2025. DOI: 10.1016/j.jacadv.2025.102164.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.